Absence of mood switch with and tolerance to modafinil: A replication study from a large private practice

Journal of Affective Disorders

Volumn 95, Issue 1-3, 2006, Pages 111-114

  Nasr, Suhayl ^a   Wendt, Burdette ^a   Steiner, Kathryn ^a  

^a Nasr Psychiatric Services   (United States)

Author keywords

Modafinil; Switching; Tolerance

Indexed keywords

MODAFINIL;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; SUBSTANCE ABUSE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG TOLERANCE; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; RETROSPECTIVE STUDIES;

EID: 33846198001     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.01.010     Document Type: Article

References (23)

1. Boerlin H.L., Gitlin M.J., Zoellner K.A., and Hammen C.L. Bipolar depression and antidepressant-induced mania: a naturalistic study. J. Clin. Psychiatry 59 (1998) 374-379
2. Bransfield R.C. Potential uses of modafinil in psychiatric disorders. J. Appl. Res. 4 (2004) 198-207
3. Carlson P.J., Merlock M.C., and Suppes T. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disord. 6 5 (2004) 416-420
4. DeBattista C., Solvason H.B., Kendrick E., and Schatzberg A.F. Modafinil as adjunctive in treatment of fatigue and hypersomnia in major depression. Poster Presentation at the American Psychiatric Association Annual Meeting, New Orleans, LA (2001) May
5. Doghramji K., Menza M.A., Rosenthal M.H., and Fieve R.R. Adjunct modafinil for fatigue and wakefulness in MDD. Presented at the Annual Meeting of the American Psychiatric Association Philadelphia, PA (2002) May 19-23
6. El-Mallakh R.S. An open study of methylphenidate in bipolar depression. Bipolar Disord. 2 1 (2000) 56-59
7. Fava M., Thase M.E., and Debattista C. A multicenter placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J. Clin. Psychiatry 66 1 (2005) 85-93
8. Fawcett J., Kravitz H.M., Zajecka J.M., and Schaff M.R. CNS stimulant potentiation of monomine oxidase inhibitors in treatment-refractory depression. J. Clin. Psychopharmacol. 11 (1991) 127-132
9. Feighner J.P., Herbstein J., and Damlouji N.F. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. J. Clin. Psychiatry 46 (1985) 206-209
10. Ghaemi S.N., Rosenquist K.J., Ko J.Y., Baldassano C.F., Kontos N.J., and Baldessarini R.J. Antidepressant treatment in bipolar versus unipolar depression. Am. J. Psychiatry 161 (2004) 163-165
11. Goldberg J.F., and Truman C.J. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord. 5 (2003) 407-420
12. Jasinski D. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J. Psychopharmacol. 14 (2000) 53
13. Judd L.L., Akiskal H.S., Schettler P.J., Coryell W., Endicott J., Maser J.D., Solomon D.A., Leon A.C., and Keller M.B. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry 60 (2003) 261-269
14. Lin J.S., Hou Y., and Jouvet M. Potential brain neuronal targets for amphetamine-methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14128-14133
15. Menza M.A., Kaufman K.R., and Castellanos A. Modafinil augmentation of antidepressant treatment in depression. J. Clin. Psychiatry 61 5 (2000) 378-381
16. Mitchell P.B., Wilhelm K., Parker G., Austin M.P., Rutgers P., and Malhi G.S. The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J. Clin. Psychiatry 62 (2001) 212-216
17. Myrick H., Malcolm R., Taylor B., and LaRowe S. Modafinil: preclinical, clinical, and post-marketing surveillance-a review of abuse liability issues. Ann. Clin. Psychiatry 16 2 (2004) 101-109
18. Nasr S. Modafinil as adjunctive therapy in depressed outpatients. Ann. Clin. Psychiatry 16 3 (2004) 133-138
19. Rush C.R., Kelly T.H., Hays L.R., Baker R.W., and Wooten A.F. Acute behavioral and physiological effects of modafinil in drug abusers. Behav. Pharmacol. 13 2 (2002) 105-115
20. Soutullo C.A., DelBello M.P., Ochsner J.E., MCElroy S.L., Taylor S.A., Strakowski S.M., and Keck P.E. Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J. Affect. Disord. 70 3 (2002) 323-327
21. Vorspan F., Warot D., Consoli A., Cohen D., and Mazet P. Mania in a boy treated with modafinil for narcolepsy. Am. J. Psychiatry 162 (2005) 813-814
22. Warot D., Corruble E., Payan C., Weil J.S., and Puech A.J. Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo. Eur. Psychiatry 8 (1993) 201-208
23. Zis A.P., and Goodwin F.K. Major affective disorder as a recurrent illness: a critical review. Arch. Gen. Psychiatry 20 36 (1979) 835-839